Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
2.420
-0.430 (-15.09%)
At close: Apr 24, 2026, 4:00 PM EDT
2.410
-0.010 (-0.42%)
After-hours: Apr 24, 2026, 7:58 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $199.83 million as of April 24, 2026. Its market cap has decreased by -64.51% in one year.
Market Cap
199.83M
Enterprise Value
7.03M
1-Year Change
-64.51%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has decreased from $467.51M to $199.83M, a decrease of -57.26%. That is a compound annual growth rate of -10.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 199.83M | -73.79% |
| Dec 31, 2025 | 762.47M | -18.18% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 214.02M |
| OmniAb | 211.38M |
| Enlivex | 210.91M |
| Nkarta | 208.17M |
| Context Therapeutics | 207.65M |
| Caribou Biosciences | 205.84M |
| MacroGenics | 202.76M |
| Karyopharm Therapeutics | 195.23M |